2Fischer I,Gagner JP,Law M, et al. Angiogenesis in gliomas: biology and molecular Pathophysiology [J]. Brain Pathol, 2005,15(4) :297 - 310.
3Oshika Y, Nakamura M, Tokunaga T, et al. Ribozyme approach to downregulate vascular endothelial growth factor (VEGF) 189 expression in nonsmall cell lung cancer (NSCLC)[J]. European Journal of Cancer. 2000,36(18): 2390 - 2396.
4Sledge GW Jr. Vascular endothelial growth factor in breast cancer,biologic and the rapeutic aspects[J]. Sere in Oncol, 2002,29(3 suppl 11) :104- 110.
5G Graccone. EGFR inhibitors in the treatment of lung cancer [J]. EJC,2003,1(5) :$106.
6Hicklin DJ,Ellis LM. Role of the Vascular Endothelial Growth Factor PathWay in Growth and Angiogenesis[J]. Journal of Clinical Ontology,2005,23(5): 1011.
7Bachelder RE, Wendt MA, Mercurio Am. Vascular endothelial growth factor promotes carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4[J]. Cancer Res,2002,62(24) :7203.
8Sun FY,Guo X. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor[J]. J Neuro Sci Res, 2005,79 : 180 - 184.
10Takano S,Yoshii Y,Kondo S,et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients[J]. Cancer Res, 1996, 56 (9): 2185 - 2190.
9Serrano M, Hannon GJ, Beach D. A new regulatory motif in cellcycle control causing specific inhibition of cyclin D/CDK4 [ J ].Nature, 1993,366(6 456) :704～707.
10Kamb A, Gruis NA, Weaver-Feldnaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types[ J ].Science, 1994,264(5 157) :436～440.
3Fujiwaki R, Hata K, Iida K, et al. Vascular endothelial growth factor expression in progress of cervical cancer: correlation with thymidine phosphoryl expression, angiogenesis, tumor cell prolif- eration,and apoptosis[J]. Anticancer Res, 2000,20 (2B) : 1317- 1322.
4Sioud M, siRNA delivery in vivo[J]. Methods Mol Biol, 2005, 309 : 237-249.
5Mulkeen AL,Silva T, Yoo PS, et al. Short interfering RNA-me- diated gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells[J]. Arch Surg, 2006,141 (4) : 367- 374.
6Qiu S,Adema CM,Lane T. A computational study of off- target effects of RNA interference[J]. Nucleic Acids Res, 2005,33 (6) 1834-1847.
7Schwarz DS, Ding H, Kennington L, et al. Designing siRNA that distinguish between genes that differ by a single nucleotide[J]. PLoS Genet,2006,2(9):e140.
8Bremnes RM, Camps C, Sirera R. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood[ J ]. Lung Cancer,2006,51(2): 143-158.
9Hammes LS, Tekmal RR, Naud P, et al. Up-regulation of VEGF, c- fins and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease [ J ]. Gynecol Oncol, 2008,110(3) : 445-451.
10Samouelian V, Revillion F, Alloy N, et al. Measurement of mR- NA of 11 biomarkers by RT-PCR to detect lymph node involve- ment in cervical cancer[J]. Int J Biol Markers, 2008,23 (2) : 74- 82.
